Chakshu Initiates New Trial for Treating Cataract…
Chakshu has initiated a trial to determine the safety and efficacy of our eyedrop in improving visual acuity relative to placebo in patients with age-related cataract. Recruiting is underway at various sites throughout the United States. You can access more information on this trial, including contact information for enrollment, at ClinicalTrials.gov